Quick Answer
GUIDED THERAPEUTICS INC reported Stockholders Equity of -$6.01 million for the year ending 2025.
- GUIDED THERAPEUTICS INC showed a decrease of -22.8% in Stockholders Equity from 2024 to 2025.
- This data is from GUIDED THERAPEUTICS INC's annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2019: -$16.01 million | Q2 2019: -$18.59 million | Q1 2020: -$11.35 million | Q2 2020: -$16.42 million | Q3 2020: -$13.82 million | Q1 2021: -$7.99 million | Q2 2021: -$7.99 million | Q3 2021: -$7.75 million | Q1 2022: -$4.99 million | Q2 2022: -$5.77 million | Q3 2022: -$2.65 million | Q1 2023: -$2.86 million | Q2 2023: -$3.32 million | Q3 2023: -$3.65 million | Q1 2024: -$4.01 million | Q2 2024: -$4.67 million | Q3 2024: -$4.92 million | Q1 2025: -$5.03 million | Q2 2025: -$5.47 million | Q3 2025: -$5.65 million.
- Over the full 17 years of available data (2009 to 2025), GUIDED THERAPEUTICS INC's Stockholders Equity has grown by 49.8%.
- Historical annual values: Fiscal year 2025: -$6.01 million | Fiscal year 2024: -$4.89 million | Fiscal year 2023: -$3.81 million | Fiscal year 2022: -$2.88 million | Fiscal year 2021: -$5.45 million | Fiscal year 2020: -$10.86 million | Fiscal year 2019: -$16.94 million | Fiscal year 2018: -$15.82 million | Fiscal year 2017: -$19.40 million | Fiscal year 2016: -$9.27 million | Fiscal year 2015: -$5.56 million | Fiscal year 2014: -$4.47 million | Fiscal year 2013: -$107.0 thousand | Fiscal year 2012: $1.13 million | Fiscal year 2011: $1.58 million | Fiscal year 2010: $1.01 million | Fiscal year 2009: -$11.98 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: